Related by context. All words. (Click for frequent words.) 78 AACR NCI EORTC 75 EORTC NCI AACR Symposium 73 EORTC NCI AACR 70 #nd EORTC NCI 69 Gastrointestinal Cancers Symposium 68 Antimicrobial Agents 68 ASH Annual Meeting 68 Opportunistic Infections CROI 67 Chemotherapy ICAAC 67 #th Annual Interscience 67 Cancer Therapeutics 67 Retroviruses 66 Biological Therapy 66 Alzheimer Disease ICAD 66 AACR San Antonio 66 Genitourinary Cancers Symposium 66 AACR #st Annual Meeting 66 ASCO Annual Meeting 66 AACR Symposium 65 nd Annual Meeting 65 Therapeutics TCT scientific 65 AACR symposium 65 Opportunistic Infections 65 Society CTOS 64 Infectious Diseases ECCMID 64 Clinical Oncology Annual Meeting 64 Hematology ASH Annual Meeting 64 annual Transcatheter Cardiovascular 64 Gynecologic Cancer Society 64 Symposium SABCS 64 #th Interscience Conference 63 Hematology Annual Meeting 63 Annual Scientific Sessions 63 ICAAC 63 Clinical Oncology ASCO Annual 63 Breast Cancer Symposium 63 Digestive Disease Week DDW 63 EORTC NCI 63 st Annual Meeting 63 Transcatheter Cardiovascular Therapeutics TCT 63 SABCS 62 AUA Annual Meeting 62 Annual Transcatheter Cardiovascular 62 ASCO GI 62 Late Breaker 62 Medical Oncology ESMO 62 Arteriosclerosis Thrombosis 62 ECCMID 62 CROI 62 Malignant Lymphoma 62 #st Annual Meeting 61 CTRC AACR San Antonio 61 th Interscience Conference 61 Therapeutics TCT 61 UEGW 61 Poster Presentation 61 Liver EASL 61 Endocrine Society Annual Meeting 61 Digestive Disease Week 61 Connective Tissue Oncology 61 ICAAC IDSA 61 Cancers Symposium 60 International Myeloma Workshop 60 Targeted Anticancer Therapies 60 Cancer iSBTc 60 ECCO ESMO 60 Prostate Cancer Symposium 60 Interscience Conference 60 EASL 60 Related Disorders ICAD 60 Endocrine Society ENDO 60 Poster Session 60 League Against Rheumatism 59 Preclinical Data 59 AACR #nd Annual Meeting 59 Scientific Meeting 59 #rd Annual CTRC 59 Vascular Biology ATVB 59 AACR Annual Meeting 59 Scientific Sessions 59 AASLD 59 Hematology ASH 59 Selective Cardiac Myosin 59 Combination REOLYSIN R 59 AACR Meeting 59 Clinical Trial Results 58 ECTRIMS 58 #nd Annual Meeting 58 European CanCer Organisation ECCO 58 AACR IASLC Joint 58 Transcatheter Cardiovascular Therapeutics 58 ERA EDTA 58 Abstract Number 58 Gastrointestinal Cancer 58 AASLD Meeting 58 Diabetes EASD 58 Molecular Medicine Tri 58 Neoplasia 58 Antiviral Research 58 Preclinical Study 58 Melanoma Skin Cancers 58 Rheumatology ACR Annual 58 Oral Presentation 58 Breast Cancer Symposium SABCS 58 FOLOTYN ® 58 Related Viruses 58 Dendritic Cells 58 Therapeutic Targets 57 Scientific Session 57 Safety Tolerability 57 Therapeutic Radiology 57 ISPOR 57 Hsp# Inhibitor 57 ASCO Breast Cancer 57 Venereology EADV 57 Oral Fingolimod 57 Cambridge Healthtech Institute 57 AAO HNSF Annual Meeting 57 Association EHA 57 Clinical Microbiology 57 Rheumatology Annual 57 Abstract # 57 ORAL Sync 57 AHA Scientific Sessions 57 Chicago Multidisciplinary Symposium 57 MT# MEDI 57 AACR EORTC NCI 57 Electro Optics CLEO 57 entitled Synergistic 57 Clinical Oncology ASCO 56 Annual ICAAC 56 Preclinical Efficacy 56 ACR ARHP 56 AACR NCI EORTC Molecular 56 AABB Annual Meeting 56 Brentuximab Vedotin SGN 56 Digestive Diseases Week 56 Randomized Phase 56 Hematology Meeting 56 transthyretin TTR mediated amyloidosis 56 pralatrexate injection folate analogue 56 EULAR Annual 56 Presents Positive 56 AACR 56 Cardiovascular Disease Epidemiology 56 AACR Frontiers 56 SAEM Annual Meeting 56 ESMO 56 Liver Diseases AASLD 56 Presents Preclinical Data 56 Annual Interscience Conference 56 ASCO Genitourinary Cancers Symposium 56 Metastatic Melanoma 56 AAN Annual Meeting 56 journal Antimicrobial Agents 56 Phase 2a Study 56 CYT# potent vascular disrupting 56 Nephrology Renal Week 55 compound AEZS 55 histone deacetylase HDAC inhibitor 55 ADA Scientific Sessions 55 Oncology ASTRO 55 HCV NS5B polymerase 55 ESTRO 55 Romidepsin 55 E CENP E 55 KRN# 55 Recurrent Chest Wall 55 novel VDA molecule 55 ENDO 55 NASDAQ CYTK announced 55 EuroPCR 55 & OTO EXPO 55 BIO InvestorForum 55 Cardiovascular Renal Physiology 55 BIOCOM Investor Conference 55 Sangamo BioSciences Announces 55 Advanced Neuroendocrine Tumors 55 Haemostasis ISTH 55 Canaccord Adams Hepatitis C 55 IEEE MTT S 55 targeting CD# 55 ASMS Conference 55 Endovascular Therapy ISET 55 ASCO Gastrointestinal Cancers Symposium 55 Pediatric Academic Societies 55 Gene Therapy ASGT 55 Kinase Inhibitor 55 San Antonio Breast Cancer 55 II Clinical Trial 55 Gynecologic Investigation 54 evaluating tivozanib 54 Announces Poster Presentations 54 ongoing Phase 1b 54 Oral Presentations 54 PROSTASCINT R 54 Inc. Nasdaq IMGN 54 BiTE R 54 Solorel TM 54 pan HDAC inhibitor 54 RCW Breast Cancer 54 ACR ARHP Annual 54 Phase 2b Clinical Trial 54 sorafenib tablets 54 mitogen activated ERK kinase 54 Tumor Biology 54 Selective Cardiac Myosin Activator 54 IL# PE#QQR 54 Therapeutics Roundtable 54 Targeted Therapies 54 Proc Am Soc 54 Phase #/#a trial 54 Long Awaited Reality 54 Endocrine Society #st 54 Neuroendocrinology 54 oral FTY# 54 Liver Diseases 54 NuroPro ® AD 54 AAG geldanamycin analog 54 taxane resistant 54 fosbretabulin 54 Pooled Analysis 54 Completes Patient Enrollment 54 International Papillomavirus 54 RNAi Therapeutic 54 HIV Pathogenesis Treatment 54 oral proteasome inhibitor 54 Double Blind Placebo 54 Annual BIO 54 DG# compounds targeting 54 GTCbio 54 Pediatric Academic Societies PAS 54 Cancer Therapeutic 54 ASCO GU 54 Drugs Affecting Lipid 54 Neuropathic Pain 54 Solid Tumors 54 liposome injection 54 Endocrine Society #nd 54 Poster Presentations 54 Presents Preclinical 54 Neurology AAN 53 orally inhaled migraine 53 dose escalation clinical 53 registrational Phase 53 Novel Oral 53 LSE ASM 53 CTRC AACR 53 Environ Health Perspect 53 BiTE ® 53 novel histone deacetylase 53 number NCT# ClinicalTrials.gov 53 Multiple Sclerosis ECTRIMS 53 non nucleoside inhibitor 53 Immunology Annual Meeting 53 Neck Surgery Foundation 53 RECORD1 53 Gastroenterology ACG Annual 53 abstr 53 Keystone Symposia 53 Urology EAU 53 ARVO 53 Developmental Therapeutics Immunotherapy 53 Genitourinary Cancer 53 Randomized Phase II 53 Inflammatory Arthritis 53 GTCbio 3rd 53 Cachexia 53 Neurology Annual Meeting 53 Neuro Oncology SNO 53 AIDS Vaccine 53 Antiviral Activity 53 ExTRACT TIMI 53 Clinical Oncology Gastrointestinal Cancers 53 vascular disrupting agent 53 GASTRO 53 Edge STudy 53 BRIM3 53 SPIE Photonics West 53 Thoracic Oncology 53 lexidronam injection 53 Molecular Cancer 53 selective kinase inhibitor 53 American Roentgen Ray 53 Hormone Refractory Prostate Cancer 53 Clinical Oncology ASCO Gastrointestinal 53 th Annual Interscience 53 JAK2 Inhibitor 53 Research IADR 53 www.hematology.org 53 EADV 53 HIV Pathogenesis 53 HDAC Inhibitors 53 Reports Preclinical Data 53 Carfilzomib 53 Vascular Annual Meeting 53 Poster Discussion 53 Vascular Biology 53 Ocular Diseases 53 Cardiology ESC Congress 53 Hematological Malignancies 53 HCV polymerase inhibitors 52 abstracts summarizing 52 randomized discontinuation trial 52 VEITHsymposium 52 Tanespimycin 52 Biodefense Vaccines 52 International Microwave Symposium 52 J Am Coll 52 Personalized Immunotherapy 52 Randomized Double blind 52 NSTI Nanotech 52 PEG SN# 52 plus Copegus R 52 Venereology 52 Genital Infection 52 Experimental Biology Annual Meeting 52 NicVAX TM 52 radezolid 52 ZFP Therapeutic 52 Interventional Radiology SIR 52 HDAC Inhibitor 52 Controlled Release 52 TIDES Oligonucleotide 52 alpha antagonist 52 Molecular Origins 52 Cancer Immunotherapy 52 HCV SPRINT 52 PNP inhibitor 52 Elvitegravir 52 Room #AB [002] 52 Pharmacoeconomics 52 delafloxacin 52 metastatic castration resistant 52 AAAS Annual Meeting 52 Vaccine Adjuvant 52 depsipeptide 52 Phase Ib II 52 Dose Escalation 52 Endovascular Valve Edge 52 Oncology ESTRO 52 Heart Failure Society 52 oral prodrug 52 Meets Primary Endpoint 52 ALN TTR 52 FASEB J. 52 SUCCEED trial 52 R lenalidomide 52 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 52 ThermoDox ® clinical 52 Fifth Decennial International 52 EpCAM 52 Active Biotech NASDAQ OMX 52 & Renshaw Techvest 52 Lysosomal Disease Network 52 OMP #M# 52 Female Urology 51 paclitaxel cisplatin 51 phase IIb study 51 Advanced Renal Cell 51 J.P. Morgan Healthcare 51 bazedoxifene conjugated estrogens 51 www.asco.org 51 orally administered inhibitor 51 Randomized Phase III 51 Free Full Text 51 antibody MT# 51 Respiratory Viral Infections 51 Cardiostim 51 Nordic ACTI 51 RGB # 51 & Immunology AAAAI 51 Safinamide 51 Nephrology Annual Meeting 51 Deforolimus 51 BCIRG 51 www.aacr.org 51 Relapsing Multiple Sclerosis 51 CLEO QELS 51 Phase #b/#a clinical 51 Retrovirus Conference 51 preclinical efficacy 51 pancreatic colon 51 Therapeutic Radiation 51 Clinical Antipsychotic Trials 51 Outcomes Research ISPOR 51 EMBO J. 51 Gastrointestinal Oncology 51 INSPIRE Trial Phase III 51 Lung Transplantation 51 Epileptology 51 CCX# 51 Chronic Lymphocytic Leukemia 51 ABCSG 51 Pacifico Yokohama Japan 51 Midyear Clinical Meeting 51 CR# vcMMAE 51 journal Arteriosclerosis Thrombosis 51 Suppl. 51 MT#/MEDI-# 51 Radiation Oncology ASTRO 51 worsening thrombocytopenia 51 EASD 51 America HFSA 51 Retina Specialists 51 Nasdaq IDRA today 51 NEUVENGE 51 Castration Resistant Prostate Cancer 51 Myelodysplastic Syndromes 51 Arch Neurol 51 Global Healthcare Unplugged 51 Infectious Disease ECCMID 51 Anticancer Drugs 51 CRLX# 51 Frankfurt XMP 51 EORTC 51 PEGylated interferon beta 1a 51 Metabolic Disorders 51 huC# DM4 51 CEQ# 51 Pharmacokinetics 51 EVEREST II 51 Novel Therapeutics 51 Renshaw 9th 51 Am J Pathol 51 Cancer Cachexia 51 www.telik.com 51 iSBTc 51 Neuropsychopharmacology 51 Vaccine Immunology 51 Preclinical Studies 51 Refractory Angina 51 Autoimmunity 51 Annual EuroMeeting 51 Phase 2a 51 Spine Arthroplasty Society 51 recurrent glioblastoma multiforme 51 PROVENGE sipuleucel T 51 Immunotherapeutic 51 HFSA Annual 51 alvespimycin 51 Respiratory Society 51 Phase Ib Clinical Trial 51 ASBMR 51 Applied Spectroscopy 51 Endovascular Therapy 51 Hematology 51 Phase 2a Trial 51 ASGT 51 Arch Surg 51 J Clin Oncol 51 Canaccord Genuity Growth 51 EACTS 51 Neurodegenerative Disease 51 Clinical Virology Symposium 50 Communications ECOC 50 EUROGIN 50 BiOS 50 BRIM2 50 Stem Cell Research ISSCR 50 Oral Abstract 50 TLR antagonists 50 Symposium Seminar 50 APOPTONE 50 Hematology ASH Meeting 50 MEK inhibitor 50 ECNP 50 FOLFOX6 chemotherapy regimen 50 Lung Cancer IASLC 50 trial evaluating PRX# 50 Annual Canaccord Adams 50 AIR2 Trial 50 SCAI Annual 50 Prolongs Survival 50 essential thrombocythemia ET 50 vivo efficacy 50 Nephrology ASN Renal 50 Movement Disorder 50 Breaking Clinical Trials 50 Podium Presentation 50 Traficet EN 50 pharmacokinetic PK 50 SAR# [004] 50 Nasdaq ENZN 50 Diabetologia 50 Cardiol 50 preclinical pharmacokinetic 50 Chemotherapy ICAAC Infectious Diseases 50 Gastroenterology ACG 50 Microplasmin 50 www.micromet inc.com 50 USpella 50 LBH# 50 Antiviral Therapy 50 ® DDW 50 coronary stent merged 50 PERSEUS 50 Pharmaceutical Scientists AAPS 50 Aflibercept 50 Experimental Biology 50 HCV protease 50 pertuzumab 50 Phase III ALLEGRO 50 Announces Presentation 50 cetuximab Erbitux 50 ASCO abstract 50 BR.# 50 histone deacetylase inhibitor 50 EULAR 50 Intervention Effectiveness 50 TÎ ² 4 50 Beneficial Effects 50 #th Annual Retrovirus 50 Trandolapril 50 Radiation Oncology Biology 50 HCV Protease Inhibitor 50 AS# amonafide L malate 50 Cardiovascular Interventions 50 NASDAQ IDRA 50 Clinical Trials Update 50 Phase 2a Clinical Trial 50 QLT# 50 Ann Rheum Dis 50 antibody blinatumomab MT#/MEDI-# 50 Thermo Scientific booth 50 AEZS 50 ASTRO Annual Meeting 50 ThermoDox R 50 Nasdaq SNSS 50 Initiates Clinical Trial 50 Inc. Nasdaq AVRX 50 recurrent malignant glioma 50 metaglidasen 50 IN PATIENTS WITH 50 Therapeutic Radiation Oncology 50 Systemic Delivery 50 CTAP# Capsules 50 TORISEL TM 50 mGluR5 negative 50 Enzastaurin 50 Gastroenterology Week UEGW 50 TG MV 50 Hematology Molecular Pathology 50 Aggressive Reduction 50 Ocular Pharmacology 50 ASM Biodefense 50 NASDAQ SLXP today 50 Acute Ischemic Stroke 50 BiTE antibody MT# 50 Human Brain Mapping 50 ZYBRESTAT fosbretabulin 50 NYSE Amex RGN 50 EGFR HER2 50 Anti Tumor 50 GVAX ® 50 Small Molecule 49 Interventions SCAI 49 Phase 2a clinical 49 American Thoracic Society 49 Molecular Diagnostics 49 Novel Inhibitor 49 pelvic malignancies 49 Cell Biology ASCB 49 ErbB2 positive 49 Outpatient Setting 49 microsphere therapy 49 NASDAQ INHX 49 TMC# C# 49 Overactive Bladder OAB 49 ARRS Annual Meeting 49 American Psychosomatic Society 49 Optical Fiber Communication 49 PSN# [002] 49 Tumor Microenvironment 49 Ann Oncol 49 ASH Abstract # 49 entinostat 49 DDW 49 SEMICON Europa 49 BioProcess International 49 Hedgehog Pathway Inhibitor 49 Oncol 49 Am J Geriatr 49 Inc. Nasdaq BIOD 49 J Am Soc 49 assessing T DM1 49 ganetespib 49 JAK2 inhibitor 49 ISSWSH 49 angiogenesis inhibitor 49 phase Ib 49 Phase III AFFIRM 49 Omacetaxine 49 #:#-# [031] 49 Peer Reviewed Journal 49 DIA EuroMeeting 49 Blinatumomab 49 ANN INTERN MED 49 Addex Pharmaceuticals SIX ADXN 49 AEG# 49 Antibody Therapeutics 49 Nephrol Dial Transplant 49 Potent Antiviral Activity 49 COPIC Energy 49 teriflunomide 49 NASDAQ CXSP announced 49 Experimental Medicine 49 PI3K/mTOR 49 ARVO Annual Meeting 49 AAPS Annual Meeting 49 multicenter Phase II 49 RADIANT 49 Acute Myocardial Infarction 49 Elagolix 49 www.nejm.org 49 Trofex 49 R roscovitine 49 Phase III ADT 49 Phase 1b trial 49 huN# DM1 49 Well Tolerated 49 Ophthalmology ARVO 49 anti amnesic 49 panobinostat 49 Clin Chem 49 programs visit http:/www.bionovo.com 49 Inc. OTCBB LPTN 49 Hypertension ESH 49 First Patient Enrolled 49 Innate Immunity 49 ENDEAVOR III 49 Denufosol 49 Exhibitor Profiles 49 catheter occlusion 49 Pediatric Academic Society 49 Neck Cancer 49 Belimumab 49 Oncologic 49 abnormal p# 49 ON #.Na 49 prostate cancer mCRPC 49 Sipuleucel T 49 Neuropharmacology 49 Microbiology ASM 49 Maven Semantic 49 Multiple Myeloma MM 49 GRN#L 49 phase IIb clinical 49 #:#-# [007] 49 Annual Meeting 49 Am J Epidemiol 49 DIA Annual Meeting 49 Phase Ib clinical trials 49 HIF PH inhibitors 49 Recombinant Human 49 recurrent glioma 49 Wadih Arap 49 including eniluracil ADH 49 Autoimmune Diseases 49 selective inhibition 49 EchoCRT 49 HUPO 49 Pharmacodynamics 49 MTT S 49 CE Unterberg Towbin Emerging 49 discussed NuroPro Power3 49 J Natl Cancer Inst 49 Physiology Seminar 49 ABRF 49 Clinical Efficacy 49 oral JAK1 49 DU #b 49 rd Annual 49 EGS# 49 INGN 49 rALLy clinical trial 49 CA4P 49 Cardiovascular Anesthesiologists 49 ALN VSP 49 Diabetic Macular Edema DME 49 Inc. NASDAQ HEPH 49 Prostate AdenoCarcinoma Treatment 49 Retina Specialists ASRS 49 Initiated Phase 49 Oligonucleotide Therapeutics Society 49 Liver Transplantation 49 CALGB # [002] 49 Cancer MASCC 49 PROactive Study 49 Mass Spectrometry ASMS 49 NO# [002] 49 REG2 49 trastuzumab DM1 49 Molecular Therapy 48 Deutsches Herzzentrum 48 Cites Positive 48 Amrubicin 48 omacetaxine mepesuccinate 48 Nephrol 48 CLARITY study 48 Epilepsy Society 48 International Neuropsychological Society 48 Cloretazine R 48 Experimental Biology EB 48 Cystic Fibrosis Conference NACFC 48 Biophysical Society 48 HER2 positive metastatic breast 48 See CLINICAL PHARMACOLOGY 48 EDEMA3 trial 48 seliciclib CYC# 48 Monoclonal Antibodies 48 Romiplostim 48 Plastic Surgeons ASPS Plastic 48 Haemostasis 48 oral ridaforolimus 48 Gaylord Palms Hotel 48 Ambrisentan 48 Human Genetics ASHG 48 Nasdaq SGMO announced 48 Molecular Markers 48 Guanilib 48 MERIT ES 48 metastatic colorectal 48 Clinical Oncology 48 Tissue Engineering 48 OXi# 48 Bone Marrow Transplantation 48 comparing alemtuzumab 48 Phacilitate Vaccine Forum 48 ECNP Congress 48 sulodexide 48 General Psychiatry #:#-#,# 48 randomized controlled Phase 48 EFNS 48 LD Micro 48 resistant hormone refractory 48 Thrombosis 48 Annual Institutional Investor 48 Preclinical 48 Pirfenidone 48 J Clin Endocrinol Metab 48 Chronic Lymphocytic Leukemia CLL 48 midstage clinical 48 Phase 2a trial 48 HCV RESPOND 2 48 Cloretazine ® 48 PRNewswire FirstCall Tercica 48 Eur Respir J 48 Pivotal Clinical Trial 48 HDL Selective Delipidation 48 Inflammatory Bowel Diseases 48 Bortezomib 48 RNAi Therapeutics 48 HepaSphere 48 Kahalalide F 48 #:#-# [023] 48 Abstract Accepted 48 evaluating mipomersen 48 Mineral Research ASBMR 48 Rheumatology EULAR 48 Neuroendocrine 48 ACM SIGCOMM 48 ELACYT 48 SU# [003] 48 ACC.# 48 BioCentury Future Leaders 48 undergoing elective percutaneous 48 Wound Healing Society 48 http:/www.hematology.org 48 Bladder Cancer 48 Cardiovascular Therapeutics 48 PKC# 48 JAK1 48 www.pranabio.com 48 forodesine 48 Oligonucleotides 48 Hand ASSH 48 PXD# 48 YONDELIS R 48 BRAF inhibitor 48 Pre RELAX AHF 48 CLARITY TIMI 48 PSMA ADC 48 treat nicotine addiction 48 OvaRex R 48 Aplidin R 48 CIMZIA TM certolizumab pegol 48 Int J Epidemiol 48 CTI Nasdaq 48 IRX 2 48 Refractive Surgery ASCRS 48 HGS ETR1 48 NASDAQ ARRY 48 Angiology 48 Stent Thrombosis 48 Diabetic Foot 48 Physiology Endocrinology 48 Thromb Haemost 48 evaluating carfilzomib 48 CALGB 48 plenary lecture 48 J Clin Invest 48 GSK # 48 CombAT 48 Pluristem Therapeutics 48 Liposomal 48 Hematological 48 Clinical Psychopharmacology 48 Sym# 48 DASISION 48 Phase Ib study 48 Liver Disease AASLD 48 prospective multicentre 48 PreCISe 48 Metabolic Disease 48 Nasdaq GNTA 48 Inc. Nasdaq ATHX 48 induces apoptosis 48 Continence Society 48 Nasdaq CYCC Nasdaq CYCCP 48 EOquin TM 48 Phase Ib clinical 48 substudy 48 www.rxipharma.com 48 Hospital Universitari 48 varespladib 48 Institutional Investor Forum 48 Biologic Therapy 48 XL# SAR# 48 Inc. Nasdaq CRTX 48 EXPAREL ™ 48 fidaxomicin Phase 3 48 Nat Med 48 HORIZONS AMI 48 INCB# [001] 48 Dr. Gulfo 48 Developmental Therapeutics 48 multicenter Phase 48 viral kinetic 48 BioCentury Newsmakers 48 BIO VentureForum East 48 International OARSI 47 PRNewswire FirstCall Genaera 47 Acute Heart Failure 47 epigenetic therapies 47 Glucosamine Chondroitin Arthritis 47 HDL Mimetic Peptide 47 Hagop M. 47 Phase 1b 47 Nephrology CJASN 47 Cancer Vaccines 47 Investigative Dermatology 47 Cancer EORTC 47 Bioral ® 47 Br J Haematol 47 University Hospital Gasthuisberg 47 EGEN 47 Zybrestat 47 plenary lectures 47 Pharmacoepidemiology 47 Cellular Therapy ISCT 47 #:# -# [004] 47 pharmacodynamic properties 47 Abstract P# [001] 47 Canaccord Adams Musculoskeletal 47 Endourology 47 Antisense 47 Apoptone 47 ASCO 47 Clinical Oncologists 47 DMD DMSc 47 Inhalation Solution 47 resolvin 47 DDW ® 47 HORIZONS AMI trial 47 SCCHN 47 HuMax CD4 47 #:#-# [035] 47 Malignant Mesothelioma 47 Aplidin 47 Atrial Fibrillation Symposium 47 Multilateral Initiative 47 Bipolar Disorders 47 NASDAQ PCYC 47 AVERROES 47 Usenix Security 47 M2M Evolution 47 proteasome inhibitor 47 PROSTVAC TM 47 HIF PHI 47 http:/www.palatin.com 47 HuMax EGFr 47 Annual LD MICRO 47 BiTE Antibody 47 Nasdaq INCY announced 47 COU AA 47 JMP Securities Healthcare 47 Femara letrozole 47 Panzem R NCD 47 Panzem R 47 vidofludimus 47 Interventional Oncology 47 Chest Physicians CHEST 47 PITTCON 47 Hematologic 47 Acumen BioFin Rodman 47 RNA Interference 47 Psychiatric Services #:#-#,# 47 Printable slides 47 PROTECT AF 47 Talabostat 47 Azedra 47 phase IIa clinical 47 Crit Rev 47 Anticancer Drug 47 Archexin 47 journal Hepatology 47 phase IIa 47 evaluating REVLIMID 47 Molecular Pathology 47 International Verapamil SR 47 Pediatric Oncology Branch 47 Multicenter 47 Phase III placebo controlled 47 Interventional Radiological Society 47 Embryology ESHRE 47 FDA APPROVES 47 Postgraduate Course 47 Hexvix 47 endocrine therapy 47 Cancer Res 47 CLL8 47 Canaccord Genuity Musculoskeletal 47 PI3 kinase inhibitors 47 Tarvacin TM 47 Platelet Inhibition 47 ANNUAL MEETING 47 Natixis Bleichroeder Hidden Gems 47 Windhover Therapeutic Area 47 OTO EXPO 47 MOZOBIL 47 AVADO 47 Remote Sensing ASPRS 47 Phase #/#a 47 Glufosfamide 47 verteporfin 47 Cardiology Scientific Sessions 47 YONDELIS 47 IMiDs R 47 ThinkEquity Growth 47 Experimental Neurology 47 www.palatin.com 47 Electro Optics Society 47 neratinib 47 multiple myeloma MM 47 Hypertension ASH 47 Preventive Oncology 47 maximally tolerated dose 47 HGS# 47 XL# XL# XL# 47 NASDAQ TARG 47 Boceprevir 47 visit www.dobimedical.com 47 Natalizumab 47 ZYBRESTAT TM 47 Cellular Immunology 47 Perifosine 47 RECIST Response Evaluation Criteria 47 dasatinib Sprycel 47 Phase 2b trial 47 Clinical Dermatology 47 relapsing remitting MS RRMS 47 Nasdaq IMGN 47 alpha7 47 Inc. NASDAQ SGEN 47 multicentric 47 Bazedoxifene 47 Fondaparinux 47 lymphomas leukemias 47 CAPRISA 47 Oncolytic Viruses 47 Xcytrin R 47 PEARL HF 47 Inc. Nasdaq VRUS 47 Daclizumab 47 CRMD# 47 ENESTnd 47 Cellular Therapy 47 Novalis Circle 47 Abstracts 47 novel trazodone formulation 47 journal Molecular 47 Cardiology ESC 47 Ophthalmic Drugs Advisory 47 MATCHED 47 Clinical Trial Data 47 isoform selective 47 Medicinal Chemistry Letters 47 TASKi2